Comparative Study Between Intravitreal Injection of Triamcinolone Acetonide, Bevacizumab and Combination of Both in The Management of Diabetic Macular Edema
MONA KAMAL ABDELATIF;
Abstract
I
n this study, we compared three types of intravitreal injections for the treatment of DME. Group A received 4mg/0.1ml intravitreal triamcinolone acetonide, group B received 1.25mg/0.05ml intravitreal bevacizumab, and group C received 1.25mg/0.05ml intr
n this study, we compared three types of intravitreal injections for the treatment of DME. Group A received 4mg/0.1ml intravitreal triamcinolone acetonide, group B received 1.25mg/0.05ml intravitreal bevacizumab, and group C received 1.25mg/0.05ml intr
Other data
| Title | Comparative Study Between Intravitreal Injection of Triamcinolone Acetonide, Bevacizumab and Combination of Both in The Management of Diabetic Macular Edema | Other Titles | دراسة مقارنة بين تأثير حقن التريامسينولون, البيفاسيزوماب وكليهما داخل الجسم الزجاجى على إرتشاح الماقولة السكرى | Authors | MONA KAMAL ABDELATIF | Keywords | Comparative Study Between Intravitreal Injection of Triamcinolone Acetonide, Bevacizumab and Combination of Both in The Management of Diabetic Macular Edema | Issue Date | 2010 | Description | I n this study, we compared three types of intravitreal injections for the treatment of DME. Group A received 4mg/0.1ml intravitreal triamcinolone acetonide, group B received 1.25mg/0.05ml intravitreal bevacizumab, and group C received 1.25mg/0.05ml intr |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 91646Mona Kamal Thesis.pdf | 307.34 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.